Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
MWN-AI** Summary
Cosmos Health Inc. (NASDAQ:COSM), a diversified global healthcare group, has made a significant move by expanding its Sky Premium Life® product line into Kuwait through an exclusive distribution agreement with Diyar United, signed on September 28, 2025. This partnership positions Diyar United—a well-established distributor in Kuwait—with exclusive rights for registering, marketing, and distributing Sky Premium Life® nutraceuticals within the country, which includes popular formulations like collagen, hyaluronic acid, vitamins, and various food supplements targeted for health and wellness.
The initial phase of this collaboration has already resulted in a purchase order exceeding 65,000 units, indicating a robust demand for Cosmos Health's offerings in Kuwait. The Kuwaiti nutritional supplements market, valued at approximately $1.16 billion in 2024, is projected to experience noteworthy growth, anticipated to reach around $1.68 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3%. This market trajectory confirms a substantial opportunity for Cosmos Health as it seeks to establish a strong foothold in the Middle East.
CEO Greg Siokas highlighted the potential of this exclusive agreement, emphasizing Diyar United's expertise in healthcare distribution as a crucial factor for successful market penetration. He reiterated the company's commitment to expanding the Sky Premium Life brand globally to meet the rising consumer demand for high-quality nutraceutical products.
With a history of innovation and a portfolio boasting proprietary brands, Cosmos Health continues to focus on strategic partnerships and market expansions as part of its broader growth strategy. As the company develops its sales pipeline in Kuwait, it also looks to enhance its global presence, solidifying its role in the competitive landscape of health and wellness products.
MWN-AI** Analysis
Cosmos Health Inc. (NASDAQ:COSM) has recently made a significant move by securing an exclusive distribution agreement with Diyar United to market its Sky Premium Life line of nutraceuticals in Kuwait. This strategic expansion taps into a lucrative market projected to grow from $1.16 billion in 2024 to $1.68 billion by 2030, indicating a robust annual growth rate of 6.3%. Such a market environment creates an opportune moment for Cosmos to establish its footprint in the region.
The initial purchase order of over 65,000 units underscores strong demand and suggests the potential for sustained sales as Cosmos builds on this foundation. Diyar United's established presence and logistical expertise in Kuwait positions Cosmos Health for a successful market entry. Moreover, as consumer health awareness rises, the demand for dietary and nutraceutical supplements often outpaces traditional pharmaceutical offerings, which further bolsters the outlook for Cosmos Health's product line.
Investors should be aware that while the agreement represents a positive growth trajectory for Cosmos, it also comes with inherent risks typical of market expansions, including compliance with local regulations, competition within the nutraceutical space, and supply chain challenges. The company's reported diversification into telehealth through its ZipDoctor acquisition and ongoing R&D efforts to innovate in pharmaceuticals are also important growth avenues that could enhance shareholder value.
In summary, Cosmos Health Inc. presents a compelling opportunity for investors seeking exposure to the growing nutraceutical sector in the Middle East. The company's strategic partnerships and market positioning could drive both revenue growth and brand recognition. long-term investors should consider this expansion as part of a broader portfolio strategy, while remaining mindful of possible market risks associated with international scaling efforts.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its subsidiary, SkyPharm S.A., has entered into an exclusive distribution agreement, dated as of September 28, 2025, with Diyar United for the marketing and sale of its Sky Premium Life® line of nutraceuticals in Kuwait.
Diyar United is a respected distributor in Kuwait with extensive healthcare experience. Its strong network, supported by proven logistics and regulatory expertise, makes it a reliable partner to drive Cosmos Health’s expansion into the Kuwaiti market.
Under the agreement, Diyar United will hold the exclusive rights for the registration, promotion, logistics, and distribution of Sky Premium Life® food supplements in Kuwait, spanning formulations such as collagen, hyaluronic acid, vitamins B, C and D3 with K2, magnesium, zinc, turmeric, maca, rhodiola, multivitamins, and hair, skin and nail support blends.
Cosmos Health has secured an initial purchase order of over 65,000 units, reflecting strong demand expectations, with further orders anticipated as the Company builds a growing sales pipeline in Kuwait.
According to Grand View Research , Kuwait’s nutritional supplements market was valued at approximately $1.16 billion in 2024 and is projected to reach $1.68 billion by 2030, growing at a CAGR of around 6.3%. This robust market outlook underscores the significant opportunity for Cosmos Health and its Sky Premium Life® brand as they expand into the country.
Greg Siokas, CEO of Cosmos Health, stated: “This agreement in Kuwait is yet another strong validation of the growing global demand for our Sky Premium Life products. By partnering with Diyar United, a highly respected distributor with proven market expertise, we are confident in our ability to expand successfully in the Middle East. This milestone further reinforces our global growth strategy and advances our mission of establishing Sky Premium Life as a trusted and recognized nutraceutical brand worldwide.”
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website ( www.sec.gov ). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
Disclaimer
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.
FAQ**
How does Cosmos Holdings Inc. COSM plan to leverage its partnership with Diyar United to penetrate and grow its market share in the Kuwaiti nutraceutical sector, given the projected growth of the nutritional supplements market there?
What specific strategies does Cosmos Holdings Inc. COSM have in place to ensure consistent supply and distribution of its Sky Premium Life® products in Kuwait, considering the challenges of entering a new international market?
Can Cosmos Holdings Inc. COSM provide more details on its anticipated sales pipeline and marketing approach in Kuwait to attract consumers to its range of nutraceuticals under the exclusive distribution agreement?
With the nutritional supplements market in Kuwait projected to experience a CAGR of around 6.3%, how does Cosmos Holdings Inc. COSM intend to capitalize on this growth trend to expand its brand recognition and sales within the region?
**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).
NASDAQ: COSM
COSM Trading
10.1% G/L:
$0.2758 Last:
1,618,807 Volume:
$0.2525 Open:
